Tian Zeng

513 total citations
29 papers, 344 citations indexed

About

Tian Zeng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Tian Zeng has authored 29 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Tian Zeng's work include Cancer-related molecular mechanisms research (6 papers), Epigenetics and DNA Methylation (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Tian Zeng is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Epigenetics and DNA Methylation (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Tian Zeng collaborates with scholars based in China. Tian Zeng's co-authors include Juan Zou, Zufan Zhang, Yukun Li, Shaohui Sun, Yukun Li, Juan Zou, Wenchao Zhou, Dan Mo, Qing Wu and Xin Zeng and has published in prestigious journals such as Analytical Chemistry, Scientific Reports and Analytica Chimica Acta.

In The Last Decade

Tian Zeng

25 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tian Zeng China 11 184 99 90 64 48 29 344
Jin-Wan Park South Korea 6 257 1.4× 94 0.9× 85 0.9× 33 0.5× 39 0.8× 38 416
Xinwang Yuan China 9 317 1.7× 127 1.3× 133 1.5× 57 0.9× 45 0.9× 13 479
Xuechao Jia China 10 193 1.0× 43 0.4× 74 0.8× 38 0.6× 24 0.5× 14 298
Fayong Hu China 8 291 1.6× 215 2.2× 168 1.9× 41 0.6× 64 1.3× 12 563
Christalle C. T. Chow Japan 6 368 2.0× 284 2.9× 113 1.3× 64 1.0× 46 1.0× 8 549
Yujia Zhao China 11 153 0.8× 61 0.6× 82 0.9× 75 1.2× 51 1.1× 34 392
Jelena Milovanović Serbia 9 118 0.6× 73 0.7× 187 2.1× 34 0.5× 83 1.7× 25 332
Rocío López‐Vacas Spain 10 159 0.9× 96 1.0× 78 0.9× 67 1.0× 30 0.6× 23 316
Ganggang Mu China 11 180 1.0× 101 1.0× 139 1.5× 127 2.0× 53 1.1× 12 489

Countries citing papers authored by Tian Zeng

Since Specialization
Citations

This map shows the geographic impact of Tian Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian Zeng more than expected).

Fields of papers citing papers by Tian Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tian Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian Zeng. The network helps show where Tian Zeng may publish in the future.

Co-authorship network of co-authors of Tian Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Tian Zeng. A scholar is included among the top collaborators of Tian Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian Zeng. Tian Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Haoyu, Yuqing Wang, Qingfeng Li, et al.. (2025). Comparison of adverse events between intensity-modulated radiation therapy and tomotherapy for early stage breast cancer: a retrospective cohort study. Frontiers in Oncology. 15. 1654609–1654609.
2.
Zeng, Tian, Yitong Liu, Xing Tang, et al.. (2025). BCAA metabolism: the Achilles’ heel of ovarian cancer, polycystic ovary syndrome, and premature ovarian failure. Frontiers in Endocrinology. 16. 1579477–1579477.
3.
4.
5.
Zhou, Wenchao, Tian Zeng, Junling Chen, et al.. (2024). Aberrant angiogenic signaling pathways: Accomplices in ovarian cancer progression and treatment. Cellular Signalling. 120. 111240–111240. 8 indexed citations
6.
Xie, Juan, et al.. (2024). ANGPTL4 plays a paradoxical role in gastric cancer through the LGALS7 and Hedgehog pathways. Scientific Reports. 14(1). 23173–23173. 2 indexed citations
7.
Gao, Anbo, Tian Zeng, Dan Liu, et al.. (2024). ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1. Journal of Translational Medicine. 22(1). 46–46. 28 indexed citations
8.
Tang, Xiaojun, Lingli Luo, Wenchao Zhou, et al.. (2024). Deoxypodophyllotoxin Mediates Autophagy Death through Inhibition of GRP78 in Human Osteosarcoma. Current Cancer Drug Targets. 25(9). 1118–1133.
9.
Hao, Jie, Junyi Wang, Yan Dong, et al.. (2023). Homogeneous, Simple, and Direct Analysis of Exosomal PD-L1 via Aptamer-Bivalent-Cholesterol-Anchor Assembly of DNAzyme (ABCzyme) for Tumor Immunotherapy. Analytical Chemistry. 95(17). 6854–6862. 15 indexed citations
10.
Li, Yingxue, Tian Zeng, Junyi Wang, et al.. (2023). Accurate and rapid quantification of PD-L1 positive exosomes by a triple-helix molecular probe. Analytica Chimica Acta. 1251. 340984–340984. 9 indexed citations
11.
Zhang, Juan, Yan Li, Yan Li, et al.. (2022). Comprehensive analysis of the glutathione S-transferase Mu (GSTM) gene family in ovarian cancer identifies prognostic and expression significance. Frontiers in Oncology. 12. 968547–968547. 18 indexed citations
12.
13.
Hu, Chunyan, et al.. (2021). Significance of chromobox protein (CBX) expression in diffuse LBCL. Gene. 813. 146092–146092. 3 indexed citations
14.
Zeng, Tian, Lei Zhang, Can Chen, et al.. (2021). Durable Complete Response to Pembrolizumab in Esophageal Squamous Cell Carcinoma With Divergent Microsatellite Status: A Case Report. Frontiers in Oncology. 11. 767957–767957. 2 indexed citations
15.
Zeng, Tian, Guan Yang, Yukun Li, et al.. (2021). The DNA replication regulator MCM6: An emerging cancer biomarker and target. Clinica Chimica Acta. 517. 92–98. 37 indexed citations
16.
Hu, Yuxuan, Tian Zeng, Xiao Zheng, et al.. (2020). Immunological role and underlying mechanisms of B7‐H6 in tumorigenesis. Clinica Chimica Acta. 502. 191–198. 18 indexed citations
17.
Xu, Hao, et al.. (2019). LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway.. PubMed. 23(6). 1745–1752. 7 indexed citations
18.
Zeng, Tian, et al.. (2019). Clinical efficacy and safety of anti-PD-1/PD-L1 treatments in non-small cell lung cancer (NSCLC). Artificial Cells Nanomedicine and Biotechnology. 47(1). 4194–4201. 10 indexed citations
19.
Mo, Dan, et al.. (2015). Low PBRM1 identifies tumor progression and poor prognosis in breast cancer.. PubMed. 8(8). 9307–13. 10 indexed citations
20.
Wu, Jin, Tian Zeng, Xinyu Wu, et al.. (2012). Ether à go-go 1 Silencing in Combination with TRAIL Overexpression Has Synergistic Antitumor Effects on Osteosarcoma. Cancer Biotherapy and Radiopharmaceuticals. 28(1). 65–70. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin-Wan Park Breakdown of academic impact, for papers by Xinwang Yuan Breakdown of academic impact, for papers by Xuechao Jia Breakdown of academic impact, for papers by Fayong Hu Breakdown of academic impact, for papers by Christalle C. T. Chow Breakdown of academic impact, for papers by Yujia Zhao Breakdown of academic impact, for papers by Jelena Milovanović Breakdown of academic impact, for papers by Rocío López‐Vacas Breakdown of academic impact, for papers by Ganggang Mu
Rankless by CCL
2026